The Stanford IBD Symposium will be a dynamic forum supporting interactive learning across disciplines. The expert, multi-disciplinary faculty will present data and facilitate active discussions on a diverse variety of topics including the microbiome and diet, the importance of incorporating patient-centered care, best clinical practices using recently-approved therapies, and innovations in endoscopic and surgical approaches. Case-based discussions and networking will be integrated into this thought-provoking and stimulating educational meeting.
Date & Location
Friday, March 13, 2020, 7:30 AM – 6:00 PM, Paul Brest Hall- Munger Bldg 4, Stanford, CA
Target Audience
Family Medicine & Community Health, Gastroenterology & Hepatology, Internal Medicine, Surgery
Family Medicine & Community Health, Gastroenterology & Hepatology, Internal Medicine, Surgery
Objectives
At the conclusion of this activity, participants should be able to:
- Discuss the clinical management of Crohn’s Disease and Ulcerative Colitis
- Identify the latest therapies to treat IBD and their potential side effects
- Review preventative health for people with IBD
- Optimize the care of IBD patients using the latest endoscopic and surgical management techniques
Accreditation
The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.